Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unidom Participações is a Brazilian healthcare holding company that operates a network of specialized oncology clinics under the brand Unidom (União de Clínicas de Oncologia). Headquartered in Salvador, Bahia, the company provides a wide range of cancer care services, including chemotherapy, radiotherapy, and hematological treatments. In 2021, Unidom was acquired by Oncoclínicas, the largest provider of oncology services in Latin America, to strengthen its presence in the Brazilian Northeast. The company is known for its multidisciplinary approach, integrating medical oncology with support services such as nutrition and psychology. Unidom also participates in clinical trials, offering patients access to innovative therapies and advanced treatment protocols. Its facilities are equipped with modern technology to support the entire patient journey from diagnosis to survivorship.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unidom Participações.